[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.148.181. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
July 1973

Palliative Treatment of Mammary CancerResponse of Soft Tissue, Pleural and Pulmonary Disease

Author Affiliations

Los Angeles
From the Department of Surgery, University of Southern California School of Medicine and Los Angeles County-University of Southern California Medical Center. Dr. Donovan is now with the University of South Alabama, Mobile.

Arch Surg. 1973;107(1):43-48. doi:10.1001/archsurg.1973.01350190033010
Abstract

Sequential palliative therapy has been employed during 333 courses of therapy for primary inoperable, recrudescent chest wall, regional nodal, and pleural and pulmonary manifestations of mammary cancer. Objective regression occurred following institution of 28% of the courses and stability of previously progressive disease during an additional 19%.

A favorable therapeutic response (regression or stability) occurred in 42% of estrogen-rich patients following oophorectomy. Adrenalectomy was followed by a favorable response in 66% of patients with prior favorable response to oophorectomy. A 57% rate of favorable response occurred with estrogenic steroid administration to estrogen-poor patients. The rate of favorable response to single-agent chemotherapy was disappointing. Fifty percent of patients who responded favorably at some time survived for over 18 months; only 5% of patients who never responded favorably survived for over 18 months.

×